Dx & Vx Co., Ltd. Logo

Dx & Vx Co., Ltd.

A bio-healthcare company specializing in diagnostics and mRNA vaccine development.

180400 | KO

Overview

Corporate Details

ISIN(s):
KR7180400004
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로 173, 금천구

Description

Dx & Vx Co., Ltd. is a bio-healthcare company specializing in diagnostics and vaccine development. Its diagnostics division offers molecular diagnostic solutions, genomics and bioinformatics services, and customized companion diagnostics (CDx), leveraging an AI-based genome analysis platform. The company's therapeutic pipeline is centered on an innovative mRNA vaccine platform designed for long-term storage at room temperature. Key development areas include vaccines for infectious diseases, immuno-therapeutic cancer vaccines, oral treatments for obesity, and therapies for eye conditions. Additionally, Dx & Vx provides contract development, manufacturing, and sales organization (CDMO/CSO) services and commercializes microbiome-based products and health supplements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주식등의대량보유상황보고서(약식)
Korean 121.1 KB
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2025-09-16 00:00
주주총회소집결의 (임시주주총회)
Korean 8.4 KB
2025-09-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.7 KB
2025-08-29 00:00
합병등종료보고서(자산양수도)
Korean 15.2 KB
2025-08-14 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 13.3 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.8 MB
2025-08-14 00:00
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.1 KB
2025-08-14 00:00
[기재정정]사업보고서 (2024.12)
Korean 2.4 MB
2025-07-30 00:00
투자판단관련주요경영사항 (mRNA항암백신 공동연구 및 기술이전계약 체결)
Korean 10.7 KB
2025-07-30 00:00
주요사항보고서(타법인주식및출자증권양도결정)
Korean 19.8 KB
2025-07-21 00:00
주식등의대량보유상황보고서(약식)
Korean 82.4 KB
2025-05-27 00:00
단기차입금증가결정
Korean 9.2 KB
2025-05-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.6 MB

Automate Your Workflow. Get a real-time feed of all Dx & Vx Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dx & Vx Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dx & Vx Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cessatech A/S Logo
A biotech company developing medicines for children's acute pain management.
Denmark
CESSA
CG Invites Co., Ltd. Logo
A biopharmaceutical company specializing in digital genomics and personalized medicine.
South Korea
083790
CG Oncology, Inc. Logo
Develops bladder-sparing oncolytic immunotherapies for urologic cancers.
United States of America
CGON
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapeutics using proprietary adjuvant platforms.
South Korea
261780
Develops and manufactures veterinary medicines and functional feed additives.
South Korea
052670
Chemical Works of Gedeon Richter Plc Logo
Vertically integrated pharma company focused on women's health and other therapies.
Hungary
RICHT
Chemomab Therapeutics Ltd. Logo
Clinical-stage biotech developing therapeutics for fibro-inflammatory diseases.
United States of America
CMMB
CHINA PHARMA HOLDINGS, INC. Logo
Develops, manufactures, and markets prescription, OTC, and nutritional products.
United States of America
CPHI
China SXT Pharmaceuticals, Inc. Logo
Researches, develops, manufactures, and sells traditional Chinese medicine products.
United States of America
SXTC
ChoA Pharmaceutical Co., LTD. Logo
Develops, manufactures, and sells pharmaceutical products and health supplements.
South Korea
034940

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.